Popular New
- Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics501 daysAnnals of the rheumatic diseasesRead
- Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study501 daysAnnals of the rheumatic diseasesRead
- The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series501 daysAnnals of the rheumatic diseasesRead
- Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)501 daysAnnals of the rheumatic diseasesRead
- Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) by Giollo et al501 daysAnnals of the rheumatic diseasesRead
- COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs501 daysAnnals of the rheumatic diseasesRead
- Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic dru501 daysAnnals of the rheumatic diseasesRead
- Rheumatic diseases in intensive care unit patients with COVID-19501 daysAnnals of the rheumatic diseasesRead
- Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19 by Moiseev et al501 daysAnnals of the rheumatic diseasesRead
- What is the true incidence of COVID-19 in patients with rheumatic diseases?501 daysAnnals of the rheumatic diseasesRead
- Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?501 daysAnnals of the rheumatic diseasesRead
- Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)? by Moiseev et al501 daysAnnals of the rheumatic diseasesRead
- Patients with lupus are not protected from COVID-19501 daysAnnals of the rheumatic diseasesRead
- No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit501 daysAnnals of the rheumatic diseasesRead
- SLE patients are not immune to covid-19: importance of sending the right message across501 daysAnnals of the rheumatic diseasesRead
- Response to: 'Patients with lupus are not protected from COVID-19: a comment by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit by Romao et al and 'SLE pati501 daysAnnals of the rheumatic diseasesRead
- Are patients with systemic lupus erythematosus at increased risk for COVID-19?501 daysAnnals of the rheumatic diseasesRead
- Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19? by Favalli et al501 daysAnnals of the rheumatic diseasesRead
- Correction: Knee osteoarthritis risk in non-industrial societies undergoing an energy balance transition: evidence from the indigenous Tarahumara of Mexico501 daysAnnals of the rheumatic diseasesRead
- Correction: High prevalence of spondyloarthritis-like MRI lesions in postpartum women: a prospective analysis in relation to maternal, child and birth characteristics501 daysAnnals of the rheumatic diseasesRead
- Glucocorticoids: surprising new findings on their mechanisms of actions501 daysAnnals of the rheumatic diseasesRead
- Johann Lucas Schoenlein (1793-1864): impact without publications501 daysAnnals of the rheumatic diseasesRead
- Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)501 daysAnnals of the rheumatic diseasesRead
- Tackling osteoarthritis during COVID-19 pandemic501 daysAnnals of the rheumatic diseasesRead
- Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting501 daysAnnals of the rheumatic diseasesRead
- Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis501 daysAnnals of the rheumatic diseasesRead
- Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden501 daysAnnals of the rheumatic diseasesRead
- In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells501 daysAnnals of the rheumatic diseasesRead
- Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials501 daysAnnals of the rheumatic diseasesRead
- Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block501 daysAnnals of the rheumatic diseasesRead
- Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial501 daysAnnals of the rheumatic diseasesRead
- Proteomic, biomechanical and functional analyses define neutrophil heterogeneity in systemic lupus erythematosus501 daysAnnals of the rheumatic diseasesRead
- Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database501 daysAnnals of the rheumatic diseasesRead
- Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement501 daysAnnals of the rheumatic diseasesRead
- Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort501 daysAnnals of the rheumatic diseasesRead
- Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group501 daysAnnals of the rheumatic diseasesRead
- Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids501 daysAnnals of the rheumatic diseasesRead
- Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study501 daysAnnals of the rheumatic diseasesRead
- SARS CoV-2 infection among patients using immunomodulatory therapies501 daysAnnals of the rheumatic diseasesRead
- Greetings from the editor 2021530 daysAnnals of the rheumatic diseasesRead
- Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India530 daysAnnals of the rheumatic diseasesRead
- Antirheumatic agents in covid-19: is IL-6 the right target?530 daysAnnals of the rheumatic diseasesRead
- COVID-19 cytokine storm: what is in a name?530 daysAnnals of the rheumatic diseasesRead
- The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India by Gupta et al and 'Antirheuma530 daysAnnals of the rheumatic diseasesRead
- Online management of rheumatoid arthritis during COVID-19 pandemic530 daysAnnals of the rheumatic diseasesRead
- Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: 'Online management of rheumatoid arthritis during COVID-19 pandemic by Zhang et al530 daysAnnals of the rheumatic diseasesRead
- The role of TASL in the pathogenesis of SLE: X marks the spot530 daysAnnals of the rheumatic diseasesRead
- Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?530 daysAnnals of the rheumatic diseasesRead
- Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality? by Xie et al530 daysAnnals of the rheumatic diseasesRead
- Jan Mikulicz-Radecki (1850-1905): return of the surgeon530 daysAnnals of the rheumatic diseasesRead
Quick Link
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology